Whole body de novo amino acid synthesis in type I (insulin-dependent) diabetes studied with stable isotope-labeled leucine,
alanine, and glycine. Diabetes January 1985 34:67-73; doi:10.2337/diabetes.34.1.67
Studies on the possible involvement of prostaglandins in insulin generation of pyruvate dehydrogenase activator. Diabetes January 1985 34:29-37; doi:10.2337/diabetes.34.1.29
Whole body de novo amino acid synthesis in type I (insulin-dependent) diabetes studied with stable isotope-labeled leucine,
alanine, and glycine. Diabetes January 1985 34:67-73; doi:10.2337/diabetes.34.1.67
Metabolism of low-density lipoprotein from patients with diabetic hypertriglyceridemia by cultured human skin fibroblasts.
Diabetes January 1985 34:8-14; doi:10.2337/diabetes.34.1.8
Metabolism of low-density lipoprotein from patients with diabetic hypertriglyceridemia by cultured human skin fibroblasts.
Diabetes January 1985 34:8-14; doi:10.2337/diabetes.34.1.8
Age- and diabetes-related changes in tissue glucose uptake and estradiol accumulation in the C57BL/KsJ mouse. Diabetes January 1985 34:47-52; doi:10.2337/diabetes.34.1.47
Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry. Diabetes January 1985 34:53-59; doi:10.2337/diabetes.34.1.53
The effects of cyclooxygenase and lipoxygenase inhibitors on the collagen abnormalities of diabetic rats. Diabetes January 1985 34:74-78; doi:10.2337/diabetes.34.1.74
Whole body de novo amino acid synthesis in type I (insulin-dependent) diabetes studied with stable isotope-labeled leucine,
alanine, and glycine. Diabetes January 1985 34:67-73; doi:10.2337/diabetes.34.1.67
Identification of insulin variants in patients with hyperinsulinemia by reversed-phase, high-performance liquid chromatography.
Diabetes January 1985 34:1-7; doi:10.2337/diabetes.34.1.1
Identification of insulin variants in patients with hyperinsulinemia by reversed-phase, high-performance liquid chromatography.
Diabetes January 1985 34:1-7; doi:10.2337/diabetes.34.1.1
Age- and diabetes-related changes in tissue glucose uptake and estradiol accumulation in the C57BL/KsJ mouse. Diabetes January 1985 34:47-52; doi:10.2337/diabetes.34.1.47
Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry. Diabetes January 1985 34:53-59; doi:10.2337/diabetes.34.1.53
The effects of cyclooxygenase and lipoxygenase inhibitors on the collagen abnormalities of diabetic rats. Diabetes January 1985 34:74-78; doi:10.2337/diabetes.34.1.74
Metabolism of low-density lipoprotein from patients with diabetic hypertriglyceridemia by cultured human skin fibroblasts.
Diabetes January 1985 34:8-14; doi:10.2337/diabetes.34.1.8
Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry. Diabetes January 1985 34:53-59; doi:10.2337/diabetes.34.1.53
Whole body de novo amino acid synthesis in type I (insulin-dependent) diabetes studied with stable isotope-labeled leucine,
alanine, and glycine. Diabetes January 1985 34:67-73; doi:10.2337/diabetes.34.1.67
Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry. Diabetes January 1985 34:53-59; doi:10.2337/diabetes.34.1.53
Whole body de novo amino acid synthesis in type I (insulin-dependent) diabetes studied with stable isotope-labeled leucine,
alanine, and glycine. Diabetes January 1985 34:67-73; doi:10.2337/diabetes.34.1.67
The effects of cyclooxygenase and lipoxygenase inhibitors on the collagen abnormalities of diabetic rats. Diabetes January 1985 34:74-78; doi:10.2337/diabetes.34.1.74
Age- and diabetes-related changes in tissue glucose uptake and estradiol accumulation in the C57BL/KsJ mouse. Diabetes January 1985 34:47-52; doi:10.2337/diabetes.34.1.47
Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry. Diabetes January 1985 34:53-59; doi:10.2337/diabetes.34.1.53
Application of a rapid enzyme-linked immunosorbent microassay (ELISA) to study human anti-insulin antibody. Diabetes January 1985 34:60-66; doi:10.2337/diabetes.34.1.60
The effects of cyclooxygenase and lipoxygenase inhibitors on the collagen abnormalities of diabetic rats. Diabetes January 1985 34:74-78; doi:10.2337/diabetes.34.1.74
Whole body de novo amino acid synthesis in type I (insulin-dependent) diabetes studied with stable isotope-labeled leucine,
alanine, and glycine. Diabetes January 1985 34:67-73; doi:10.2337/diabetes.34.1.67
Identification of insulin variants in patients with hyperinsulinemia by reversed-phase, high-performance liquid chromatography.
Diabetes January 1985 34:1-7; doi:10.2337/diabetes.34.1.1
Studies on the possible involvement of prostaglandins in insulin generation of pyruvate dehydrogenase activator. Diabetes January 1985 34:29-37; doi:10.2337/diabetes.34.1.29
Studies on the possible involvement of prostaglandins in insulin generation of pyruvate dehydrogenase activator. Diabetes January 1985 34:29-37; doi:10.2337/diabetes.34.1.29
Application of a rapid enzyme-linked immunosorbent microassay (ELISA) to study human anti-insulin antibody. Diabetes January 1985 34:60-66; doi:10.2337/diabetes.34.1.60
The effects of cyclooxygenase and lipoxygenase inhibitors on the collagen abnormalities of diabetic rats. Diabetes January 1985 34:74-78; doi:10.2337/diabetes.34.1.74
Identification of insulin variants in patients with hyperinsulinemia by reversed-phase, high-performance liquid chromatography.
Diabetes January 1985 34:1-7; doi:10.2337/diabetes.34.1.1
Application of a rapid enzyme-linked immunosorbent microassay (ELISA) to study human anti-insulin antibody. Diabetes January 1985 34:60-66; doi:10.2337/diabetes.34.1.60
Whole body de novo amino acid synthesis in type I (insulin-dependent) diabetes studied with stable isotope-labeled leucine,
alanine, and glycine. Diabetes January 1985 34:67-73; doi:10.2337/diabetes.34.1.67
The effects of cyclooxygenase and lipoxygenase inhibitors on the collagen abnormalities of diabetic rats. Diabetes January 1985 34:74-78; doi:10.2337/diabetes.34.1.74
Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry. Diabetes January 1985 34:53-59; doi:10.2337/diabetes.34.1.53